Aspire Capital

Shares of Cerulean Pharma Inc (NASDAQ: CERU) are up over 50 percent on roughly 19 times its average volumes on Wednesday. News Behind Move The clinical-stage company said in a Businesswire release that it has struck a strategic collaboration agreement with Swiss drug giant Novartis AG (ADR) (NYSE...